Annual EBITDA
$559.74M$131.77M+30.79%
Summary
- Current Value
- As of today, BTSG annual EBITDA is $559.74M, up +30.79% on
- Historical Performance
- BTSG annual EBITDA is up +11.95% over the past 3 years, up +22.93% over the past 5 years
- All-Time High Comparison
- BTSG annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- BTSG annual EBITDA is +42.75% above its 3-year low of $392.10M reached on
- Sector Comparison
- BTSG annual EBITDA is higher than 90.40% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $559.74M | +30.8% | +11.9% | +22.9% | +258.8% | |
| Quarterly EBITDA | $186.02M | +51.2% | +27.7% | – | – | |
| TTM EBITDA | $690.27M | +41.6% | +37.3% | – | – | |
| Price | $61.71 | +173.3% | – | – | – | |
| PE Ratio | 46.09 | -38.5% | – | – | – | |
| Annual Revenue | $12.91B | +28.2% | +67.2% | +131.4% | +409.1% | |
| Annual EPS | $0.87 | +1026.9% | +375.5% | -68.8% | +155.3% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Annual Net Income | $104.80M | +252.0% | +293.3% | +395.5% | +1475.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $559.74M | at high | |
| 5Y | $559.74M | at high | |
| All | $559.74M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $392.10M | +42.8% | |
| 5Y | $392.10M | +42.8% | |
| All | $156.02M | +258.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $559.74M | +30.8% | |
| $427.96M | +9.1% | |
| $392.10M | -21.6% | |
| $500.00M | +7.0% |
| Year | Value | Change |
|---|---|---|
| $467.41M | +2.7% | |
| $455.31M | +55.7% | |
| $292.41M | +87.4% | |
| $156.02M | - |
FAQ
- What is the current annual EBITDA of BTSG?
- As of today, BTSG annual EBITDA is $559.74M
- What is 1-year change in BTSG annual EBITDA?
- BTSG annual EBITDA is up +30.79% year-over-year
- What is 3-year change in BTSG annual EBITDA?
- BTSG annual EBITDA is up +11.95% over the past 3 years
- How far is BTSG annual EBITDA from its all-time high?
- BTSG annual EBITDA is currently at its all-time high
- How does BTSG annual EBITDA rank versus sector peers?
- BTSG annual EBITDA is higher than 90.40% of companies in Healthcare sector
- When is BTSG next annual earnings release?
- As of today, the next annual earnings release for BTSG has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$186.02M$9.37M+5.31%
Summary
- Current Value
- As of today, BTSG quarterly EBITDA is $186.02M, up +5.31% on
- Historical Performance
- BTSG quarterly EBITDA is up +51.22% year-over-year, up +27.71% over the past 3 years
- All-Time High Comparison
- BTSG quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- BTSG quarterly EBITDA is +1885.88% above its 3-year low of $9.37M reached on
- Sector Comparison
- BTSG quarterly EBITDA is higher than 91.15% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $186.02M | +5.3% | +51.2% | +27.7% | – | |
| Annual EBITDA | $559.74M | – | +30.8% | +11.9% | +22.9% | |
| TTM EBITDA | $690.27M | +10.0% | +41.6% | +37.3% | – | |
| Price | $61.71 | +5.7% | +173.3% | – | – | |
| PE Ratio | 46.09 | -15.1% | -38.5% | – | – | |
| Quarterly Revenue | $3.87B | +7.2% | +23.1% | +78.8% | +135.3% | |
| Quarterly EPS | $0.39 | +17.0% | +201.8% | +1588.8% | +100.0% | |
| $144.59M | +5.1% | +78.1% | +51.5% | +104.2% | ||
| Quarterly Net Income | $86.60M | +16.6% | +914.0% | +3031.0% | +934.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $186.02M | at high | |
| 3Y | $186.02M | at high | |
| 5Y | $186.02M | at high | |
| All | $186.02M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $123.01M | N/A | +51.2% |
| 3Y | $9.37M | +1885.9% | |
| 5Y | $9.37M | +1885.9% | |
| All | $9.37M | +1885.9% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of BTSG?
- As of today, BTSG quarterly EBITDA is $186.02M
- What is BTSG quarterly EBITDA most recent change?
- BTSG quarterly EBITDA was up +5.31% on June 30, 2026
- What is 1-year change in BTSG quarterly EBITDA?
- BTSG quarterly EBITDA is up +51.22% year-over-year
- How far is BTSG quarterly EBITDA from its all-time high?
- BTSG quarterly EBITDA is currently at its all-time high
- How does BTSG quarterly EBITDA rank versus sector peers?
- BTSG quarterly EBITDA is higher than 91.15% of companies in Healthcare sector
- When is BTSG next earnings release?
- The next earnings release for BTSG is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$690.27M$63.01M+10.04%
Summary
- Current Value
- As of today, BTSG TTM EBITDA is $690.27M, up +10.04% on
- Historical Performance
- BTSG TTM EBITDA is up +41.65% year-over-year, up +37.30% over the past 3 years
- All-Time High Comparison
- BTSG TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- BTSG TTM EBITDA is +112.47% above its 3-year low of $324.88M reached on
- Sector Comparison
- BTSG TTM EBITDA is higher than 91.34% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $690.27M | +10.0% | +41.6% | +37.3% | – | |
| Annual EBITDA | $559.74M | – | +30.8% | +11.9% | +22.9% | |
| Quarterly EBITDA | $186.02M | +5.3% | +51.2% | +27.7% | – | |
| Price | $61.71 | +5.7% | +173.3% | – | – | |
| PE Ratio | 46.09 | -15.1% | -38.5% | – | – | |
| TTM Revenue | $14.37B | +5.3% | +26.4% | +76.4% | +137.8% | |
| TTM EPS | $1.34 | +24.5% | +344.2% | +338.1% | +100.0% | |
| $529.48M | +13.6% | +77.8% | +77.8% | +125.3% | ||
| TTM Net Income | $247.93M | +46.0% | +6924.3% | +350.0% | +656.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $690.27M | at high | |
| 3Y | $690.27M | at high | |
| 5Y | $690.27M | at high | |
| All | $690.27M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $487.31M | N/A | +41.6% |
| 3Y | $324.88M | +112.5% | |
| 5Y | $222.30M | +210.5% | |
| All | $103.91M | +564.3% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of BTSG?
- As of today, BTSG TTM EBITDA is $690.27M
- What is BTSG TTM EBITDA most recent change?
- BTSG TTM EBITDA was up +10.04% on June 30, 2026
- What is 1-year change in BTSG TTM EBITDA?
- BTSG TTM EBITDA is up +41.65% year-over-year
- How far is BTSG TTM EBITDA from its all-time high?
- BTSG TTM EBITDA is currently at its all-time high
- How does BTSG TTM EBITDA rank versus sector peers?
- BTSG TTM EBITDA is higher than 91.34% of companies in Healthcare sector
- When is BTSG next earnings release?
- The next earnings release for BTSG is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BTSG Official Website www.brightspringhealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1865782/000119312526079454/0001193125-26-079454-index.htm
- BTSG Profile on Yahoo Finance finance.yahoo.com/quote/BTSG
- BTSG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/btsg